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Experimental Section 
 
Materials and reagents 
All reagents purchased from commercial sources were used as received unless otherwise stated. BBL 
Trypticase Soy Agar plates with 5% Sheep Blood and Bacto Brain Heart Infusion (BHI) media were purchased 
from BD (Franklin Lakes, NJ, USA). BHI was dissolved in deionized water at the manufacturers recommended 
concentration and autoclaved prior to use. All antibiotic stock solutions and PCR reactions were prepared 
using sterile, nuclease-free water (NF-H2O) purchased from Thermo Fisher (Waltham, MA, USA).  
 
All antibiotics and clavulanic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA), with the exception 
of amoxicillin, which was purchased from Alfa-Aesar (Ward Hill, MA, USA). Ciprofloxacin and clavulanic acid 
were prepared as a 1 mg/mL stock solutions in NF-H2O. Nitrofurantoin was prepared as a 10 mg/mL stock 
solution in dimethylformamide (DMF). Sulfamethoxazole was prepared as a 10 mg/mL stock solution in 
dimethyl sulfoxide (DMSO). Trimethoprim was prepared as a 1 mg/mL stock solution in DMSO. All antibiotic 
stock solutions were stored at -20 °C. Amoxicillin was prepared fresh as a 1 mg/mL stock solution in NF-H2O 
before each experiment. 
 
QuickExtract DNA Extraction Solution and QuickExtract RNA Extraction Kit were purchased from Epicentre 
(Madison, WI, USA). SsoFast EvaGreen Supermix (2X) and QX200 ddPCR EvaGreen Supermix was 
purchased from Bio-Rad Laboratories (Hercules, CA, USA) and used for all qPCR and dPCR experiments 
respectively. 
 
Pooled human urine (catalog no. 991-03-P) was obtained from Lee Biosolutions (Maryland Heights, MO, USA). 
 
Isolate maintenance 
Ten E. coli isolated from the urine of 10 unique patients were obtained from the University of California Los 
Angeles (UCLA) Clinical Microbiology Laboratory with approval from the UCLA and Veterans Affairs 
Institutional Review Boards and appropriate Health Insurance Portability and Accountability Act exemptions. All 
isolates were identified as E. coli using the Vitek2 GNID panel (bioMerieux, Durham, NC, USA), and chosen for 
use based on their determined MICs. Urine cultures were performed by routine semi-quantitative methods, by 
inoculating 1 L of urine to a BBL Trypticase Soy Agar plate with 5% Sheep Blood (BAP, BD, Sparks MD) and 
a MacConkey plate followed by overnight incubation at 35 +/-2 °C in ambient air. In all cases, the E. coli grew 
in pure culture at  >100,000 colony forming units. Minimum inhibitory concentrations (MIC) for each isolate was 
determined by UCLA for ciprofloxacin (cip), nitrofurantoin (nit), sulfamethoxazole/trimethoprim (sxt), and 
amoxicillin/clavulanic acid (amc) using the Clinical and Laboratory Standards Institute (CLSI) reference broth 
microdilution method,[1] in panels prepared by UCLA with cation-adjusted Mueller-Hinton broth (MHB). BMD 
tests were incubated at 35 +/- 2 oC in ambient air conditions for 16-20 h. MICs were interpreted using CLSI 
M100S 26th edition breakpoints.[1]  E. coli isolates were stored at -80 °C in Brucella broth with 20% glycerol 
(Becton, Dickinson, Sparks, MD, USA). Isolates were subcultured twice on BAP and well-isolated colonies 
were used for antibiotic exposure time course experiments. 
 
Antibiotic exposure time course experiments 
In order to generate liquid culture for use in experiments, E. coli isolates were cultured overnight (10-12 hours) 
after scraping a small portion of the plate and inoculating in 4 mL BHI. Overnight cultures were re-inoculated 
into 4 mL of fresh BHI and grown for an additional 4–6 h until early logarithmic phase. Cultures were then 
diluted 10 fold into pre-warmed BHI, and optical density (600 nm) was measured using a portable 
spectrophotometer (GE Healthcare Ultrospec 10). OD was converted to approximate cell count using the 
correlation factor OD600 1.0 = 8.0*10^8 cells/mL). The dilutions prepared for OD measurements were then 
immediately diluted a second time into 2 mL polypropylene tubes to a final volume of 500 µL (dilution factor 
dependent on desired final cell concentration). These tubes were incubated for 5 min at 37 °C with shaking at 
500 rpm in a heating/shaking block (Thermo Fisher Digital Heating Shaking Drybath) to ensure thorough 
mixing. During this time, separate 2 mL polypropylene tubes containing 450 µL of BHI with and without 
antibiotics were prepared. All exposure time courses were conducted with antibiotic concentrations above the 
minimum inhibitory concentration (MIC) of the susceptible isolate and below the MIC of the resistant isolate 
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being tested. Ciprofloxacin exposure in media and urine was conducted at a final antibiotic concentration of 
2.00 and 0.75 g/mL respectively. Nitrofurantoin experiments were performed at 64.00 g/mL. 
Sulfamethoxazole/trimethoprim experiments were performed at 76.00/4.00 g/mL. For amoxicillin experiments, 
susceptible isolates were exposed to a final concentration of 12.00 g/mL, and resistant isolates were exposed 
to a final concentration of 14.00 g/mL. Cultures were then diluted a final 10 fold (50 µL culture into 450 µL) 
into single tubes containing media with or without antibiotics, and time was started. 10 µL aliquots were 
removed at 0, 15, and 30 min., and immediately mixed with 90 μL of a one-step extraction buffer suitable for 
direct use in PCR. Denaturing extraction conditions used Epicentre QuickExtract DNA Extraction Solution. 
Cells were mixed with Epicentre QuickExtract DNA Extraction Solution, pipette mixed, incubated at 65 °C for 6 
min., 98 °C for 4 min., then chilled on ice. Non-denaturing extraction conditions used Epicentre Quick Extract 
RNA Extraction solution. Aliquots were mixed with RNA extraction immediately via pipette, gently vortexed to 
ensure thorough mixing, and chilled on ice. All samples were stored at -20 °C for several days during use 
before being moved to -80 °C for long-term storage. 
 
DNA fragmentation 
DNA was fragmented to a predicted 1000 bp fragment size using a Covaris 220M ultrasonicator. Samples 
were diluted 10 fold into a 130 µL microTUBE AFA Fiber Snap-Cap, and sheered for 90 seconds at 20 °C with 
a Peak Incident Power of 50 W, duty factor of 2%, and 200 cycles per burst. This size was chosen to ensure 
that all copies of the 23S gene will be separated from each other. Based on an analysis of 11 E.coli strains 
isolated from UTIs, the average distance between 23S genes is 1,169 kb with the closest genes being 38 kb 
apart. These genomes may be accessed with the following accession numbers: CP011018.1; HG941718.1; 
CP007265.1; CP007391.1; CP002797.2; CP002212.1; CP001671.1; CU928163.2; CP000247.1; CP000243.1; 
CP011134.1. 
 
DNA quantification 
All qPCR reactions were performed using a Roche LightCycler 96. All reactions contained only SsoFast 
EvaGreen Supermix at a final concentration of 1X, forward and reverse primers (forward primer 
TGCCGTAACTTCGGGAGAAGGC, reverse primer TCAAGGCTCAATGTTCAGTGTC) specific for 
Enterobacteriaceae[2] at a final concentration of 500 nM, template DNA at variable concentrations, and NF-
H2O. A single master mix containing supermix, primers, and NF-H2O was prepared and aliquoted into PCR 
tubes. Template was then added, brining the final volume to 30 µL. Each tube was then mixed thoroughly via 
pipette and technical triplicates (9 µL each) were aliquoted into the 96 well plate. Cycling conditions consisted 
of an initial denaturation step at 95 °C for 3 min. followed by 30 cycles of 95 °C for 20 s, 62 °C for 20 s, and 72 
°C for 20 s. Following amplification a continuous melt curve was obtained between 55 and 95 °C. Total cycling 
time (including melt analysis) was 60 min. 
 
Digital PCR reactions were carried out in a BioRad QX200 Droplet Digital PCR system according to the 
manufacturer's instructions. Samples were prepared in identical fashion as those prepared for qPCR. For each 
sample, two wells of the droplet generation chip and well plate were used to generate and thermocycle 
droplets, respectively. This resulted in approximately 40,000 droplets being analyzed for each sample. Cycling 
conditions consisted of an initial denaturation step at 95 °C for 5 min followed by 40 cycles of 95 °C for 30 s, 60 
°C for 30 s, and 72 °C for 30 s. Following initial thermocycling, the sample was cooled to 4 °C for 5 min 
followed by a final heating step at 95 °C for 5 min. All thermocycling steps were performed with a 2 °C/s ramp 
rate. Total cycling time was 115 min. 
 
Statistical analyses 
Raw Ct values are not normally distributed; therefore, a typical plot showing the mean Ct +/- 2·SD does not 
mean that the true mean will lie in the confidence interval 95% of the time.  Understanding this fact, we would 
still like to represent the variability in qPCR measurements for the raw Ct plot.  We did this with a standard 
confidence interval calculation: 
 
 ܥݐ௎/௅ ൌ ܥݐ௔௩௚ േ ݐ௖௥௜௧ ∙ ݏ஼௤√݊ (1) 
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The critical ݐ value (ݐ௖௥௜௧) for a 98% confidence interval with 2 degrees of freedom is 4.85; with ݊ ൌ 3 replicates, 
this results in the SD being multiplied by 2.80 for the confidence intervals.  This does not mean that the true Ct 
is within this interval 98% of the time, but it does give a representation of the variability in Ct measurements. 
 
In order to calculate the p-value for comparing treated and untreated samples, the raw Ct values (which are 
exponential) were linearized into a relative quantity (ܨܥ) with t = 0 min as the reference point using ܨܥ ൌ
2஼௧ሺ௧ሻି஼௧ሺ଴ሻ.  The log ratio of these linearized quantities was compared to ln(1.1) using a one-tailed ݐ test.  A one-
tailed test was chosen because the untreated sample should have a higher concentration than the treated 
sample; if by some random event the treated sample has a statistically significant higher concentration than 
untreated, we don’t want to draw the false conclusion that the isolate is susceptible.  To account for pipetting 
variation (the treated sample could have randomly had 10% more bacteria pipetted into its media at time = 0 
than the untreated sample), the null hypothesis is ln ቀி஼ೠ೟ி஼೟ ቁ െ lnሺ1.1ሻ ൌ 0 instead of ln ቀ
ி஼ೠ೟
ி஼೟ ቁ ൌ 0.  This makes the AST 
more conservative (reducing very major errors) by requiring that the untreated sample have at least 1.1 fold 
more copies than the treated sample. P-values for digital PCR were calculated with a one-tailed ܼ test 
comparing ln ቀி஼ೠ೟ி஼೟ ቁ to ln	ሺ1.1ሻ, with ܨܥ௨௧ representing the fold change in concentration of the untreated sample with 
respect to time = 0 and ܨܥ௧ representing the same quantity, but for the treated sample. 
 
Discussion of mechanism of action of antibiotics tested 
In addition to ciprofloxacin, we evaluated three other antibiotics used in the treatment of UTIs: (i) nitrofurantoin, 
which is reduced to a reactive radical inside the cell, reacting with multiple cellular targets including enzyme 
involved in DNA synthesis[3], which would directly affect replication; (ii) the combination of sulfamethoxazole 
and trimethoprim, which synergistically inhibit folic acid biosynthesis, subsequently impairing multiple metabolic 
reactions including thymidine synthesis[4]; and (iii) amoxicillin, which disrupts the synthesis of the peptidoglycan 
layer of bacterial cell walls leading to lysis[5], but is not known to specifically affect DNA replication. 
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Figures and Tables 
 
 
Table S1. Minimum inhibitory concentrations for all isolates tested, as determined by broth dilution. AMC = 
amoxicillin/clavulanic acid, CIP = ciprofloxacin, NIT = nitrofurantoin, SXT = sulfamethoxazole/trimethoprim. ND = not 
determined. 
 
 
Table S2. Raw data and additional experiments performed with multiple isolates. “S or R” refers to susceptible or resistant 
as determined by MIC. ABX = antibiotic. * indicates samples were sheared prior to quantification (see methods section of 
SI). Experiment exposing isolate 1 to ciprofloxacin was performed in 1:1 media:urine, all other experiments were 
performed in media. 
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Figure S1. qPCR time course for exposure of (A) susceptible and (B) resistant UTI E. coli isolates to ciprofloxacin pre-
cultured in urine and exposed to antibiotics in 1:1 urine:BHI. Raw cycle thresholds represent the average of technical 
triplicates; error bars represent 2.8 standard deviations (see SI). Fold change values represent change from t = 0 min; 
error bars represent the upper and lower bounds of the 98% confidence interval. Significance was defined as a p-value <= 
0.02 when comparing the fold change in 23S concentration of samples incubated without antibiotics (blue) to 1.1 times the 
fold change in 23S concentration of samples with antibiotics (brown) at a specific time point. Significant differences 
detected using the susceptible isolate are marked with a green check.  
 
 
 
Figure S2. Comparison of susceptible isolate analyzed by qPCR and digital PCR after a 15 min exposure to 
amoxicillin/clavulanic acid and extracted using a denaturing buffer with protease treatment (A) and a non-denaturing 
buffer without protease treatment (B). Fold change values represent change from t = 0 min; error bars are 98% 
confidence intervals. Significance was defined as a p-value <= 0.02 when comparing the fold change in 23S concentration 
of samples incubated without antibiotics (blue) to 1.1 times the fold change in 23S concentration of samples with 
antibiotics (brown) at a specific time point. Significant and non-significant differences are marked with a green check and 
red x respectively. 
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Figure S3. Fold change plots from Figures 1 and 3 with corresponding Ct and concentration plots to demonstrate 
conversion from either Ct or concentration to fold change. (A, B) AST results using qPCR. Time course for exposure of (A) 
susceptible and (B) resistant UTI E. coli isolates to ciprofloxacin. For cycle thresholds (Ct) error bars are 2.8 S.D. Fold 
change values represent change from t = 0 min; error bars represent the upper and lower bounds of the 98% C.I. 
Significant differences (p-value ≤ 0.02) are marked with a green check. (C, D) AST results using dPCR. Time course for 
exposure of susceptible (C) and resistant (D) UTI E. coli isolates to ciprofloxacin. Concentrations are calculated using 
Poisson statistics; error bars represent the upper and lower bounds of the 98% C.I. Fold change values represent change 
from t = 0 min; error bars represent the upper and lower bounds of the 98% C.I. Significant (≤ 0.02) p-values for 
susceptible isolates are denoted with a green check.  
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